Skip to content
value.today

Visiogen Inc.

Total raised
$20 M
1 round on record
Latest round
$20 M
Apr 2009
First round on record
Apr 2009
Today
Private
No later event on record

Funding rounds

1 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Visiogen Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Apr 2009$20 MNo. 1$10 to $50 million

Visiogen Inc.: Raise no. 1, Apr 2009

Investors in this round

13 investors had bought by the notice of May 1, 2009: 13 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$20 M of $40 M offered; $20 M still to sell
Smallest investment taken
$10,000
What was sold
equity
Exemption claimed
  • 06
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in De

People named in the notice

  • Kevin Hykes · Executive Officer
  • Mitch Hill · Executive Officer
  • Reza Zadno · Executive Officer, Director
  • Andrew Firlik · Director
  • Jeani Delagardelle · Director
  • John Gilbert · Director
  • Richard Lin · Director
  • Rodney Altman · Director
  • Russell Hirsch · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Stephen Thau, Secretary. Source: SEC Form D, newest notice filed May 1, 2009. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Visiogen Inc. chose not to state its revenue in its newest notice of a funding round (May 2009).

    SEC Form D · May 2009

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · May 2009

That is all the official record says: Visiogen Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Visiogen Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 1 round above had up to 13 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Visiogen Inc.
NameRoleNamed in
Kevin HykesExecutive officerMay 2009
Mitch HillExecutive officerMay 2009
Reza ZadnoExecutive officerMay 2009
Andrew FirlikDirectorMay 2009
Jeani DelagardelleDirectorMay 2009
John GilbertDirectorMay 2009
Reza ZadnoDirectorMay 2009
Richard LinDirectorMay 2009
Rodney AltmanDirectorMay 2009
Russell HirschDirectorMay 2009